Price$17.77-0.02 (-0.11%)
01:30 PM07:45 PM
News · 26 weeks51-62%
2026-01-182026-07-12
Mix2790d
- Insider13(48%)
- SEC Filings8(30%)
- Earnings3(11%)
- Other3(11%)
Latest news
25 items- INSIDERNew insider Knoblauch Jason Fredrick claimed ownership of 275 shares (SEC Form 3)3 - Fortrea Holdings Inc. (0001965040) (Issuer)
- SECFortrea Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - Fortrea Holdings Inc. (0001965040) (Filer)
- PRFortrea Announces Date for Second Quarter 2026 Financial Results and Conference CallDURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results. To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call. The live webca
- SECFortrea Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Fortrea Holdings Inc. (0001965040) (Filer)
- PRFortrea Names Jason Knoblauch as Chief Financial OfficerDURHAM, N.C., June 26, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that Jason Knoblauch has been appointed as chief financial officer, effective July 6, 2026. He will succeed Jill McConnell, who is stepping down after successfully helping the Company become a leading, independent global CRO, and is committed to ensuring a smooth transition. "I’m delighted to welcome Jason to the Fortrea team as we continue to make advances in our strategic journey back to growth," said Anshul Thakral, CEO of Fortrea. "At the same time, I want to recognize Jill’s contributions at Fortrea and our legacy companies. We
- INSIDERDirector Sanders Machelle converted options into 38,817 shares, increasing direct ownership by 533% to 46,099 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERDirector Smith David Ross converted options into 38,817 shares and covered exercise/tax liability with 18,244 shares, increasing direct ownership by 216% to 30,117 units (SEC Form 4) (tax liability)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERDirector Pesicka Edward A converted options into 38,817 shares, increasing direct ownership by 285% to 52,453 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Director Neupert Peter M4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERChief Operating Officer Morais Mark A. sold $78,617 worth of shares (4,674 units at $16.82), decreasing direct ownership by 6% to 71,365 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERDirector Ray Amrit converted options into 38,817 shares, increasing direct ownership by 285% to 52,453 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERSEC Form 4 filed by Director Sharbaugh William J4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERDirector Russell Erin L converted options into 38,817 shares, increasing direct ownership by 115% to 72,617 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- SECFortrea Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Fortrea Holdings Inc. (0001965040) (Filer)
- PRFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization ("CRO"), today announced the granting of an inducement award of restricted stock units ("RSUs") on June 10, 2026, to 10 newly hired employees. The award consisted of 240,500 RSUs that vest in three equal annual installments starting June 10, 2027, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as
- INSIDERChief Operating Officer Morais Mark A. converted options into 11,006 shares and sold $75,374 worth of shares (4,866 units at $15.49), increasing direct ownership by 9% to 76,039 units (SEC Form 4) (tax withholding)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERChief Financial Officer Mcconnell Jill G. converted options into 11,006 shares and sold $75,374 worth of shares (4,866 units at $15.49), increasing direct ownership by 8% to 78,416 units (SEC Form 4) (withholding obligation)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- PRFortrea to Attend Jefferies Global Healthcare ConferenceDURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization ("CRO"), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference: Jefferies Global Healthcare Conference (NYC)Date: Thursday, June 4, 2026Time: 8:45 AM EDTFormat: Fireside Chat To register for the live webcast, please click here. A replay will be available in the Events & Presentations section of Fortrea's Investor Relations website. Investors interested in one-on-one or group meetings should contact their Jefferies representatives. About Fortrea Fortrea (NASDAQ:FTRE) is
- INSIDERChief Accounting Officer Parks Robert sold $26,880 worth of shares (2,000 units at $13.44), decreasing direct ownership by 9% to 20,389 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- INSIDERDirector Neupert Peter M converted options into 148,536 shares, increasing direct ownership by 151% to 246,668 units (SEC Form 4)4 - Fortrea Holdings Inc. (0001965040) (Issuer)
- SECSEC Form 144 filed by Fortrea Holdings Inc.144 - Fortrea Holdings Inc. (0001965040) (Subject)
- SECSEC Form 10-Q filed by Fortrea Holdings Inc.10-Q - Fortrea Holdings Inc. (0001965040) (Filer)
- SECFortrea Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Fortrea Holdings Inc. (0001965040) (Filer)
- PRFortrea Reports First Quarter 2026 ResultsStrong first-quarter performance reinforces confidence in FY 2026 guidanceBook-to-bill of 1.15x is third consecutive quarter above 1.1x Highlights For the three months ended March 31, 2026: Revenues of $636.5 millionBook-to-bill ratio of 1.15x, resulting in 1.05x book-to-bill for the trailing 12 monthsGAAP net loss of $(23.6) million, or $(0.25) per diluted shareAdjusted EBITDA of $47.0 millionAdjusted net income of $15.2 million, or $0.16 per diluted shareFull-year guidance affirmed DURHAM, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization ("CRO"), today reported financial results for the first quarter ended M
- SECSEC Form DEFA14A filed by Fortrea Holdings Inc.DEFA14A - Fortrea Holdings Inc. (0001965040) (Filer)
FTRE FAQ
5 questionsWhere does FTRE stock trade?
Fortrea Holdings Inc. (FTRE) is listed on NASDAQ.What sector and industry is FTRE in?
Fortrea Holdings Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about FTRE?
Fortrea Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy with a $1500.00 price target on 2026-03-09. Recent price targets range from $600.00 to $2500.00.What companies are similar to FTRE?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare FTRE side-by-side with any of them on Quantisnow.How can I track FTRE on Quantisnow?
Quantisnow aggregates Fortrea Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FTRE to receive live email and push alerts on every new disclosure.